Randomized Trialhigh evidence

Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·July 13, 2026·PMID 42441935

Why it matters

Persistent smoking after a cancer diagnosis worsens outcomes, yet tobacco treatment is rarely integrated into community oncology. This trial demonstrates that a scalable, virtual sustained intervention can nearly double quit rates in this population, providing a practical model for implementation in community settings.

Infographic summary of Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled